Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stacey Fynch

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Hepatology (Baltimore, Md.)|August 28, 2010
Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesityNirupa Sachithanandan, Barbara C Fam, Stacey Fynch, et al.
Diabetes|December 20, 2013
Deficiency in type I interferon signaling prevents the early interferon-induced gene signature in pancreatic islets but not type 1 diabetes in NOD miceHong Sheng Quah, Socorro Miranda-Hernandez, Aimee Khoo, et al.
Frontiers in Immunology|December 21, 2020
The JAK1 Selective Inhibitor ABT 317 Blocks Signaling Through Interferon-γ and Common γ Chain Cytokine Receptors to Reverse Autoimmune Diabetes in NOD MiceTingting Ge, Gaurang Jhala, Stacey Fynch, et al.
Apoptosis : an International Journal on Programmed Cell Death|June 7, 2011
The pro-apoptotic BH3-only protein Bid is dispensable for development of insulitis and diabetes in the non-obese diabetic mouseZia U A Mollah, Jibran Wali, Mark D McKenzie, et al.
Diabetes|February 1, 2013
The protective effects of CD39 overexpression in multiple low-dose streptozotocin-induced diabetes in miceJoanne S J Chia, Jennifer L McRae, Helen E Thomas, et al.
Diabetologia|January 23, 2021
Deficiency of the innate immune adaptor STING promotes autoreactive T cell expansion in NOD miceSatoru Akazawa, Leanne Mackin, Gaurang Jhala, et al.
Clinical & Translational Immunology|November 3, 2022
Diabetes induced by checkpoint inhibition in nonobese diabetic mice can be prevented or reversed by a JAK1/JAK2 inhibitorTingting Ge, Amber-Lee Phung, Gaurang Jhala, et al.
Diabetes|March 16, 2017
Repurposed JAK1/JAK2 Inhibitor Reverses Established Autoimmune Insulitis in NOD MicePrerak M Trivedi, Kate L Graham, Nicholas A Scott, et al.
Molecular Metabolism|December 10, 2021
Neuropeptide Y1 receptor antagonism protects β-cells and improves glycemic control in type 2 diabetesChieh-Hsin Yang, Danise Ann-Onda, Xuzhu Lin, et al.
EMBO Reports|February 20, 2020
ABCA12 regulates insulin secretion from β-cellsGloria M Ursino, Ying Fu, Denny L Cottle, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Hepatology (Baltimore, Md.)|August 28, 2010
Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesityNirupa Sachithanandan, Barbara C Fam, Stacey Fynch, et al.
Diabetes|December 20, 2013
Deficiency in type I interferon signaling prevents the early interferon-induced gene signature in pancreatic islets but not type 1 diabetes in NOD miceHong Sheng Quah, Socorro Miranda-Hernandez, Aimee Khoo, et al.
Frontiers in Immunology|December 21, 2020
The JAK1 Selective Inhibitor ABT 317 Blocks Signaling Through Interferon-γ and Common γ Chain Cytokine Receptors to Reverse Autoimmune Diabetes in NOD MiceTingting Ge, Gaurang Jhala, Stacey Fynch, et al.
Apoptosis : an International Journal on Programmed Cell Death|June 7, 2011
The pro-apoptotic BH3-only protein Bid is dispensable for development of insulitis and diabetes in the non-obese diabetic mouseZia U A Mollah, Jibran Wali, Mark D McKenzie, et al.
Diabetes|February 1, 2013
The protective effects of CD39 overexpression in multiple low-dose streptozotocin-induced diabetes in miceJoanne S J Chia, Jennifer L McRae, Helen E Thomas, et al.
Diabetologia|January 23, 2021
Deficiency of the innate immune adaptor STING promotes autoreactive T cell expansion in NOD miceSatoru Akazawa, Leanne Mackin, Gaurang Jhala, et al.
Clinical & Translational Immunology|November 3, 2022
Diabetes induced by checkpoint inhibition in nonobese diabetic mice can be prevented or reversed by a JAK1/JAK2 inhibitorTingting Ge, Amber-Lee Phung, Gaurang Jhala, et al.
Diabetes|March 16, 2017
Repurposed JAK1/JAK2 Inhibitor Reverses Established Autoimmune Insulitis in NOD MicePrerak M Trivedi, Kate L Graham, Nicholas A Scott, et al.
Molecular Metabolism|December 10, 2021
Neuropeptide Y1 receptor antagonism protects β-cells and improves glycemic control in type 2 diabetesChieh-Hsin Yang, Danise Ann-Onda, Xuzhu Lin, et al.
EMBO Reports|February 20, 2020
ABCA12 regulates insulin secretion from β-cellsGloria M Ursino, Ying Fu, Denny L Cottle, et al.
Pageof 3